Elanco Animal Health Announces Corporate Changes and Filings
Ticker: ELAN · Form: 8-K · Filed: 2024-06-04T00:00:00.000Z
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, financial-reporting
Related Tickers: ELAN
TL;DR
Elanco's board is changing, new execs appointed, and financials filed. Watch for governance shifts.
AI Summary
Elanco Animal Health Incorporated announced on May 30, 2024, a series of significant corporate actions. These include the election of new directors, the appointment of certain officers, and adjustments to compensatory arrangements. The company also reported on matters submitted to a vote of security holders and filed financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in leadership and governance at Elanco Animal Health, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with compensatory arrangements, can signal internal shifts that may affect company strategy and performance.
Key Players & Entities
- Elanco Animal Health Incorporated (company) — Registrant
- May 30, 2024 (date) — Date of Earliest Event Reported
- Indiana (jurisdiction) — State of incorporation
- 001-38661 (filing_id) — Commission File Number
- 82-5497352 (tax_id) — I.R.S. Employer Identification No.
- 2500 Innovation Way Greenfield, Indiana 46140 (address) — Principal executive offices
FAQ
What specific corporate actions were reported by Elanco Animal Health on May 30, 2024?
Elanco Animal Health reported the departure of directors or certain officers, the election of directors, the appointment of certain officers, and adjustments to compensatory arrangements.
What other items were included in the Form 8-K filing?
The filing also included amendments to articles of incorporation or bylaws, changes in fiscal year, submission of matters to a vote of security holders, and financial statements and exhibits.
When was the earliest event reported in this Form 8-K?
The earliest event reported was on May 30, 2024.
In which jurisdiction is Elanco Animal Health Incorporated incorporated?
Elanco Animal Health Incorporated is incorporated in Indiana.
What is the principal executive office address for Elanco Animal Health?
The principal executive office is located at 2500 Innovation Way, Greenfield, Indiana 46140.
From the Filing
0001104659-24-068253.txt : 20240604 0001104659-24-068253.hdr.sgml : 20240604 20240604161603 ACCESSION NUMBER: 0001104659-24-068253 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240530 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240604 DATE AS OF CHANGE: 20240604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825497352 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 241018254 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 8-K 1 tm2416286d1_8k.htm FORM 8-K false --12-31 0001739104 0001739104 2024-05-30 2024-05-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES   SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D. C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934     Date of Report (Date of Earliest Event Reported): May 30, 2024   Elanco Animal Health Incorporated (Exact name of registrant as specified in its charter)   Indiana   001-38661   82-5497352 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   2500 Innovation Way Greenfield , Indiana (Address of principal executive offices)   46140 (Zip Code)   Registrant’s telephone number, including area code: ( 877 ) 352-6261   Not Applicable (Former Name or Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, no par value   ELAN   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   ¨  Emerging growth company   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨           Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   As previously disclosed, the Board of Directors (the “Board”) of Elanco Animal Health Incorporated (“Elanco” or the “Company”